Concepedia

Publication | Closed Access

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

245

Citations

14

References

2017

Year

References

YearCitations

Page 1